Roche Holding Ltd (RHHVF)

$454.48 -5.82 (-1.27%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 27,600
Avg Vol 13,788
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 56%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer,...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 41 61 688 88 80
Fax: 41 61 691 00 14
Address:
Grenzacherstrasse 124, Basel, Switzerland
GoforProMIS
GoforProMIS Aug. 19 at 4:13 PM
$PMN IMO we have 5-12 pharmaceutical companies interested in PMN: $BIIB /Eisai due to high Aria of Leqembi. $RHHVF as the lost bn with Gantenerumab and need a solution. Abbvie, Bristol Myers, Novartis are keen to get into neurology as partnership. $PFE and Takeda looking for Episelect Platform! CEO Neil Warma attended and presented at Jefferies Heathcare, Oppenheimer CNS and at the Bio International Conference with the opportunity of 1to1 meetings. As the Alzheimer Conference took place on on 12-15 July the 4-6 week NDA analyses by the specialist of pharmaceutical companies should be done.
0 · Reply
GoforProMIS
GoforProMIS Jul. 16 at 11:06 AM
$PMN Big Pharma is buying up small fishes for $2,8 bn. If 1 of the big $LLY $BIIB or $ESALY or $RHHVF starts a bidding war we should see a nice run at least to MCap 1bn in the coming weeks
0 · Reply
GoforProMIS
GoforProMIS Jul. 14 at 10:25 AM
$PMN with best in class results at the Alzheimer’s Association International Conference (AAIC) as the world’s largest and most important professional conference dedicated to Alzheimer’s and dementia research. Key figures: Around 12,000 participants from across the globe attended AAIC 2025. Of these, over 8,000 attended in person, while more than 3,000 joined online. Participants came from 139 countries. Participants include: Neurologists Alzheimer’s researchers Representatives from universities Pharmaceutical companies $LLY , $BIIB , $RHHVF , $ESALY , etc. Investors and biotech analysts FDA and regulatory representatives Clinical trial investigators. Get ready for amazing day, week and months to come 🚀 https://www.promisneurosciences.com/investors/news-events/press-releases/detail/269/promis-neurosciences-reports-first-human-evidence-of
0 · Reply
clan
clan Jun. 1 at 1:43 PM
$MNKD For the good of all Mannkind, on Wednesday, the CEO speaks at the Jefferies Global Health Care conference. Afrezza c/b Blockbuster Nintedanib DPI t/b Blockbuster Tyvaso DPI is Blockbuster Ralinepag DPI t/b Blockbuster Furoscix AutoInjector t/b Blockbuster $RHHVF $RHHBY $IBB take notice.
0 · Reply
trenddetector
trenddetector Apr. 2 at 6:18 PM
$RHHVF Share this site with anyone that has cancer and is searching for options. A great resource for those confused about approved treatments and trials that are enrolling. https://nimble-frangollo-81ff5e.netlify.app/#
0 · Reply
Latest News on RHHVF
No data available.
GoforProMIS
GoforProMIS Aug. 19 at 4:13 PM
$PMN IMO we have 5-12 pharmaceutical companies interested in PMN: $BIIB /Eisai due to high Aria of Leqembi. $RHHVF as the lost bn with Gantenerumab and need a solution. Abbvie, Bristol Myers, Novartis are keen to get into neurology as partnership. $PFE and Takeda looking for Episelect Platform! CEO Neil Warma attended and presented at Jefferies Heathcare, Oppenheimer CNS and at the Bio International Conference with the opportunity of 1to1 meetings. As the Alzheimer Conference took place on on 12-15 July the 4-6 week NDA analyses by the specialist of pharmaceutical companies should be done.
0 · Reply
GoforProMIS
GoforProMIS Jul. 16 at 11:06 AM
$PMN Big Pharma is buying up small fishes for $2,8 bn. If 1 of the big $LLY $BIIB or $ESALY or $RHHVF starts a bidding war we should see a nice run at least to MCap 1bn in the coming weeks
0 · Reply
GoforProMIS
GoforProMIS Jul. 14 at 10:25 AM
$PMN with best in class results at the Alzheimer’s Association International Conference (AAIC) as the world’s largest and most important professional conference dedicated to Alzheimer’s and dementia research. Key figures: Around 12,000 participants from across the globe attended AAIC 2025. Of these, over 8,000 attended in person, while more than 3,000 joined online. Participants came from 139 countries. Participants include: Neurologists Alzheimer’s researchers Representatives from universities Pharmaceutical companies $LLY , $BIIB , $RHHVF , $ESALY , etc. Investors and biotech analysts FDA and regulatory representatives Clinical trial investigators. Get ready for amazing day, week and months to come 🚀 https://www.promisneurosciences.com/investors/news-events/press-releases/detail/269/promis-neurosciences-reports-first-human-evidence-of
0 · Reply
clan
clan Jun. 1 at 1:43 PM
$MNKD For the good of all Mannkind, on Wednesday, the CEO speaks at the Jefferies Global Health Care conference. Afrezza c/b Blockbuster Nintedanib DPI t/b Blockbuster Tyvaso DPI is Blockbuster Ralinepag DPI t/b Blockbuster Furoscix AutoInjector t/b Blockbuster $RHHVF $RHHBY $IBB take notice.
0 · Reply
trenddetector
trenddetector Apr. 2 at 6:18 PM
$RHHVF Share this site with anyone that has cancer and is searching for options. A great resource for those confused about approved treatments and trials that are enrolling. https://nimble-frangollo-81ff5e.netlify.app/#
0 · Reply